Drug Shortage Report for MINT-IRBESARTAN/HCTZ
Report ID | 71060 |
Drug Identification Number | 02393018 |
Brand name | MINT-IRBESARTAN/HCTZ |
Common or Proper name | Irbesartan- Hydrochlorothiazide |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
Strength(s) | 12.5MG 300.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 count bottles |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-01-03 |
Estimated end date | 2019-02-15 |
Actual end date | 2019-01-14 |
Shortage status | Resolved |
Updated date | 2019-01-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2019-01-16 | English | Compare |
v3 | 2019-01-04 | English | Compare |
v2 | 2019-01-03 | French | Compare |
v1 | 2019-01-03 | English | Compare |
Showing 1 to 4 of 4